Plasma protein sulfhydryl oxidation: effect of low molecular weight thiols.
van der Vliet
A
A
Department of Internal Medicine, UCD Medical Center, University of California, Sacramento 95817, USA.
Cross
C E
CE
Halliwell
B
B
O'Neill
C A
CA
D000171:Acrolein / Q000494:pharmacology; D000447:Aldehydes / Q000494:pharmacology; D001798:Blood Proteins / Q000737:chemistry* / Q000187:drug effects / Q000378:metabolism*; D006801:Humans; D007700:Kinetics; D009589:Nitrogen Oxides / Q000494:pharmacology; D010084:Oxidation-Reduction; D010126:Ozone / Q000494:pharmacology; D012907:Smoking / Q000097:blood; D013438:Sulfhydryl Compounds / Q000494:pharmacology*; D013447:Sulfites / Q000494:pharmacology; D008063:Thioctic Acid / Q000031:analogs & derivatives / Q000494:pharmacology
D000447:Aldehydes; D001798:Blood Proteins; D009589:Nitrogen Oxides; D013438:Sulfhydryl Compounds; D013447:Sulfites; D010126:Ozone; D008063:Thioctic Acid; D000171:Acrolein; C015144:dihydrolipoic acid; C012796:2-butenal; C009279:sodium bisulfite; C025026:sodium sulfite